“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Venlafaxine Hydrochloride (Venlafaxine Hydrochloride)

Trade Name : Venlafaxine Hydrochloride

Camber Pharmaceuticals, Inc.

CAPSULE, EXTENDED RELEASE

Strength 37.5 mg/1

VENLAFAXINE HYDROCHLORIDE Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Venlafaxine Hydrochloride (Venlafaxine Hydrochloride) which is also known as Venlafaxine Hydrochloride and Manufactured by Camber Pharmaceuticals, Inc.. It is available in strength of 37.5 mg/1 per ml. Read more

Venlafaxine Hydrochloride (Venlafaxine Hydrochloride) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and oldern n In patients of all ages who are started on antidepressant therapy monitor closely for clinical worsening and emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescribern
  • WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. u2022u00a0Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants () u2022u00a0Monitor for worsening and emergence of suicidal thoughts and behaviors () u2022u00a0Venlafaxine hydrochloride extended-release capsules are not approved for use in pediatric patients ()
  • Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of: u2022u00a0Major Depressive Disorder (MDD) u2022u00a0Generalized Anxiety Disorder (GAD) u2022u00a0Social Anxiety Disorder (SAD) u2022u00a0Panic Disorder (PD)
  • Venlafaxine hydrochloride extended-release capsules should be administered in a single dose with food, either in the morning or in the evening at approximately the same time each day Each capsule should be swallowed whole with fluid and not divided, crushed, chewed, or placed in water or it may be administered by carefully opening the capsule and sprinkling the entire contents on a spoonful of applesauce. This drug/food mixture should be swallowed immediately without chewing and followed with a glass of water to ensure complete swallowing of the pellets (spheroids).
  • u2022u00a0Take once daily with food (). Capsules should be taken whole; do not divide, crush, chew, or dissolve (). u2022u00a0When discontinuing treatment, reduce the dose gradually (, ). u2022u00a0Renal impairment: reduce the total daily dose by 25% to 50% in patients with renal impairment. Reduce the total daily dose by 50% or more in patients undergoing dialysis or with severe renal impairment (). u2022u00a0Hepatic impairment: reduce the daily dose by 50% in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment or hepatic cirrhosis, it may be necessary to reduce the dose by more than 50% ().
  • Venlafaxine hydrochloride extended-release capsules USP are available in the following strengths: u2022u00a037.5 mg capsules (white to off white colored, round to oval shaped pellets filled in size '3' hard Gelatin capsules with grey opaque cap imprinted with 'V' in black color, white opaque body imprinted with '9' in black color.) u2022u00a075 mg capsules (white to off white colored, round to oval shaped pellets filled in size '1' hard Gelatin capsules with peach opaque cap imprinted with 'V' in black color, white opaque body imprinted with '10' in black color.) u2022u00a0150 mg capsules (white to off white colored, round to oval shaped pellets filled in size '0' hard Gelatin capsules with orange opaque cap imprinted with 'V' in black color, white opaque body imprinted with '11' in black color.)
  • u2022u00a0Venlafaxine hydrochloride extended-release capsules are available as 37.5 mg, 75 mg and 150 mg strengths (). u2022u00a0Each capsule contains venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg or 150 mg of venlafaxine ().
  • u2022u00a0Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate, or any excipients in the venlafaxine hydrochloride extended-release capsules formulation (). u2022u00a0Do not use with an MAOI or within 14 days of stopping an MAOI. Allow 7 days after stopping venlafaxine hydrochloride extended-release capsules before starting an MAOI, because of the risk of serotonin syndrome (, , ).
  • u2022
  • Clinical Worsening/Suicide Risk:
  • u2022u00a0Serotonin Syndrome:
  • u2022u00a0Elevations in Blood Pressure:
  • u2022u00a0Abnormal Bleeding:
  • u2022u00a0Angle Closure Glaucoma:
  • u2022u00a0Activation of Mania/Hypomania:
  • 5.1
  • 4.2
  • 5.2
  • 7.3
  • 5.3
  • 5.4
  • 5.5
  • 5.6
  • The following adverse reactions are discussed in greater detail in other sections of the label: u2022u00a0Hypersensitivityn u2022u00a0Suicidal Thoughts and Behaviors in Children, Adolescents, and Adults n u2022u00a0Serotonin Syndromen u2022u00a0Elevations in Blood Pressuren u2022u00a0Abnormal Bleeding n u2022u00a0Angle Closure Glaucoman u2022u00a0Activation of Mania/Hypomania n u2022u00a0Discontinuation Syndromen u2022u00a0Seizuren u2022u00a0Hyponatremia n u2022u00a0Weight and Height changes in Pediatric Patientsn u2022u00a0Appetite Changes in Pediatric Patientsn u2022u00a0Interstitial Lung Disease and Eosinophilic Pneumonian
  • Most common adverse reactions (incidence u2265 5% and at least twice the rate of placebo): nausea, somnolence, dry mouth, sweating, abnormal ejaculation, anorexia, constipation, erectile dysfunction, and libido decreased (n n n
  • u2022 Serotonergic Drugs (e.g., MAOIs, triptans, SSRIs, other SNRIs, linezolid, lithium, tramadol, or St. John's wort):
  • 4.2
  • 5.2
  • 7.3
  • u2022u00a0Pregnancy: Based on animal data, may cause fetal harm (). u2022u00a0Nursing Mothers: Discontinue drug or nursing, taking into consideration importance of drug to mother ()
  • No data
  • No data
  • Venlafaxine hydrochloride extended-release capsules USP are an extended-release capsule for once-a-day oral administration that contains venlafaxine hydrochloride, a serotonin and norepinephrine reuptake inhibitor (SNRI). Venlafaxine is designated Cyclohexanol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride or (u00b1)-1-[u03b1-[(dimethylamino)methyl]-p-methoxybenzyl]cyclohexanol hydrochloride and has the empirical formula of CHNO HCl. Its molecular weight is 313.9. The structural formula is shown as follows:
  • Venlafaxine hydrochloride USP is a white or almost white powder, freely soluble in methanol and water, soluble in anhydrous ethanol and slightly soluble or practically insoluble in acetone. Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH-dependent. Capsules contain venlafaxine hydrochloride USP equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of ethyl cellulose, hypromellose, sugar spheres and talc. The capsule shells have the following inactive ingredients: iron oxide yellow, iron oxide red, iron oxide black, gelatin andu00a0 titanium dioxide. The printing ink contains shellac, strong ammonia solution, black iron oxide and potassium hydroxide. FDA approved dissolution specification differs from the USP dissolution specification .
  • No data
  • No data
  • No data
  • Venlafaxine hydrochloride extended-release capsules USP are available as follows: Venlafaxine hydrochloride extended-release capsules USP, 37.5 mg are white to off white colored, round to oval shaped pellets filled in size '3' hard Gelatin capsules with grey opaque cap imprinted with 'V' in black color, white opaque body imprinted with '9' in black color. Bottle of 30 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0NDC 31722-002-30 Bottle of 90 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 NDC 31722-002-90 Bottle of 500 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0 NDC 31722-002-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack)u00a0u00a0u00a0u00a0u00a0u00a0u00a0 NDC 31722-002-01 Venlafaxine hydrochloride extended-release capsules USP, 75 mg are white to off white colored, round to oval shaped pellets filled in size '1' hard Gelatin capsules with peach opaque cap imprinted with 'V' in black color, white opaque body imprinted with '10' in black color. Bottle of 30 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0u00a0NDC 31722-003-30 Bottle of 90 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0NDC 31722-003-90 Bottle of 500 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0NDC 31722-003-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack)u00a0u00a0u00a0u00a0u00a0u00a0 u00a0NDC 31722-003-01 Venlafaxine hydrochloride extended-release capsules USP, 150 mg are white to off white colored, round to oval shaped pellets filled in size '0' hard Gelatin capsules with orange opaque cap imprinted with 'V' in black color, white opaque body imprinted with '11' in black color. Bottle of 30 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 NDC 31722-004-30 Bottle of 90 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0NDC 31722-004-90 Bottle of 500 capsulesu00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 u00a0 NDC 31722-004-05 Carton of 100 (10 x 10) unit-dose capsules (Alu-Blister pack)u00a0u00a0u00a0u00a0u00a0 u00a0 NDC 31722-004-01n n
  • Arrayn- Suicidal Thoughts and Behaviorsn- [see Boxed Warning and Warnings and Precautions ()].n- Concomitant Medicationn- [see Contraindications ()].n- Serotonin Syndromen- [see Warnings and Precautions () and Drug Interactions ()].n- Elevated Blood Pressuren- [see Warnings and Precautions ()].n- Abnormal Bleedingn- [see Warnings and Precautions ()].n- Angle Closure Glaucoman- [see Warnings and Precautions ()].n- Activation of Mania/Hypomanian- [see Warnings and Precautions ()].n- Cardiovascular/Cerebrovascular Diseasen- [see Adverse Reactions ()].n- Serum Cholesterol and Triglyceride Elevationn- [see Warnings and Precautions ()].n- Discontinuation [Symptoms]n- [see Warnings and Precautions () and Adverse Reactions ()].n- Interference with Cognitive and Motor Performancen- Alcoholn- [see Drug Interactions ()].n- Allergic Reactionsn- Pregnancyn- [see Use in Specific Populations ()]. n- Nursingn- [see Use in Specific Populations ()].n- Residual Spheroids
  • Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854
  • By: Annora Pharma Pvt. Ltd.u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0u00a0 Sangareddy - 502313, Telangana, India
  • Revised: 07/2019n n
  • Medication Guide Venlafaxine Hydrochloride Extended-Release Capsules USPn- (ven'' la fax' een hye'' droe klor' ide)n- What is the most important information I should know about venlafaxine hydrochloride extended-release capsules? Venlafaxine hydrochloride extended-release capsulesn- 1. Suicidal thoughts or actions:n- Venlafaxine hydrochloride extended-release capsules and other antidepressant medicines may increase suicidal thoughts or actionsn- within the first few months of treatment or when the dose is changed.n- venlafaxine hydrochloride extended-release capsulesn- Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency, especially if they are new, worse, or worry you:n- u00a0Visual problemsn- 3. Changes in blood pressure. Venlafaxine hydrochloride extended-release capsulesn- 4. Enlarged pupils (mydriasis).n- 5. Anxiety and insomnia. 6. Changes in appetite or weight. 7. Manic/hypomanic episodes:n- 8.u00a0u00a0 Low salt (sodium) levels in the blood.n- 9.u00a0u00a0Seizures or convulsions.n- 10.u00a0Abnormal bleeding: Venlafaxine hydrochloride extended-release capsulesn- 11.u00a0Elevated cholesterol.n may cause rare lung problems. Symptoms include: u2022u00a0worsening shortness of breath u2022u00a0cough u2022u00a0chest discomfort n n u2022u00a0trouble breathing u2022u00a0swelling of the face, tongue, eyes or mouth u2022u00a0rash, itchy welts (hives) or blisters, alone or with fever or joint pain. n Stopping too quickly or changing from another antidepressant too quickly may cause serious symptoms including: u2022u00a0anxiety, irritability u2022u00a0feeling tired, restless or problems sleeping u2022u00a0headache, sweating, dizziness u2022u00a0electric shock-like sensations, shaking, confusion, nightmares u2022u00a0vomiting, nausea, diarrhea n n n are a prescription medicine used to treat depression. It is important to talk with your healthcare provider about the risks of treating depression and also the risks of not treating it. You should discuss all treatment choices with your healthcare provider. n are also used to treat: u2022u00a0Generalized Anxiety Disorder (GAD) u2022u00a0Social Anxiety Disorder (SAD) u2022u00a0Panic Disorder (PD) Talk to your healthcare provider if you do not think that your condition is getting better with treatment.n n Do not take if you: u2022u00a0are allergic to venlafaxine hydrochloride extended-release capsules or any of the ingredients in . See the end of this Medication Guide for a complete list of ingredients in n u2022u00a0have uncontrolled angle-closure glaucoma u2022u00a0take a Monoamine Oxidase Inhibitor (MAOI). Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid. u2022u00a0Do not take an MAOI within 7 days of stopping unless directed to do so by your physician. u2022u00a0Do not if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician. n- People who take venlafaxine hydrochloride extended-release capsules close in time to an MAOI may have serious or even life-threatening side effects. Get medical help right away if you have any of these symptoms: n n- What should I tell my healthcare provider before taking venlafaxine hydrochloride extended-release capsules? Ask if you are not sure.n- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloriden- venlafaxine hydrochloride extended-release capsules. n- Tell your healthcare provider about all the medicines that you taken- Venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsules
  • How should I take venlafaxine hydrochloride extended-release capsules? u2022n- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- Venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride,n- venlafaxine hydrochloride extended-release capsulesn- What should I avoid while taking venlafaxine hydrochloride extended-release capsules?n- Venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsules. n- What are the possible side effects of venlafaxine hydrochloride extended-release capsules?n- Venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsules?''n- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-releasen- capsulesn- venlafaxine hydrochloride extended-release capsulesn- CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088.n- How should I store venlafaxine hydrochloride extended-release capsules?n- venlafaxine hydrochloride extended-release capsulesn- Keep venlafaxine hydrochloride extended-release capsulesn- and all medicines out of the reach of children.n- General information about venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- venlafaxine hydrochloride extended-release capsulesn- 1-866-495-1995.n- What are the ingredients in venlafaxine hydrochloride extended-release capsules?n- Extended-Release Capsulesn- http://camberpharma.com/medication-guides
  • Arrayn- Arrayn- Array
  • Venlafaxine Hydrochloride Extended-Release Capsules USP 37.5 mg-30 Capsules
  • Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg-30 Capsules
  • Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg-30 Capsules

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.